½ÃÀ庸°í¼­
»óǰÄÚµå
1640757

¼¼°èÀÇ ¼öºÐ °ü·Ã ÇǺΠ¼Õ»ó °ü¸® ½ÃÀå : »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ¹× µ¿Çâ ¿¹Ãø(2025-2032³â)

Moisture-associated Skin Damage Management Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 188 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Persistence Market Research´Â ¼¼°èÀÇ ¼öºÐ °ü·Ã ÇǺΠ¼Õ»ó(MASD) °ü¸® ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» ¹ßÇ¥Çß½À´Ï´Ù. º» º¸°í¼­¿¡¼­´Â ½ÃÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ, °úÁ¦ µîÀÇ Áß¿äÇÑ ½ÃÀå ¿ªÇÐÀ» öÀúÈ÷ Æò°¡ÇÏ¿© ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ »ó¼¼ÇÑ ÅëÂûÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ º¸°í¼­´Â 2025³âºÎÅÍ 2032³â±îÁö ¼¼°è MASD °ü¸® ½ÃÀå ¿¹Ãø ¼ºÀå ±Ëµµ¸¦ °³·«ÀûÀ¸·Î ¼³¸íÇÏ´Â µ¶Á¡Àû µ¥ÀÌÅÍ¿Í Åë°è¸¦ Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • MASD °ü¸® ½ÃÀå ±Ô¸ð(2025³â) : 44¾ï ´Þ·¯
  • ½ÃÀå ±Ô¸ð ¿¹Ãø(±Ý¾× ±âÁØ, 2032³â) : 68¾ï ´Þ·¯
  • ¼¼°è ½ÃÀåÀÇ ¼ºÀå·ü(CAGR, 2025-2032³â) : 6.5%

¼öºÐ °ü·Ã ÇǺΠ¼Õ»ó °ü¸® ½ÃÀå : ºÐ¼® ¹üÀ§

¼öºÐ °ü·Ã ÇǺΠÀå¾Ö´Â Á¾Á¾ ½Ç±ÝÀ̳ª ¶¡¿¡ Àå½Ã°£ ³ëÃâµÇ¾î °úµµÇÑ ¼öºÐÀ¸·Î ÀÎÇÑ ÇǺΠ¼Õ»óÀ» ÀǹÌÇÕ´Ï´Ù. MASD °ü¸®´Â ´Ù¾çÇÑ ÀÇ·á±â±â, Á¦Ç° ¹× Ä¡·á¸¦ ÅëÇØ ÀÌ·¯ÇÑ ÇǺΠ»óÅÂÀÇ ¿¹¹æ, Áø´Ü ¹× Ä¡·á¿¡ ÁßÁ¡À» µÓ´Ï´Ù. MASD °ü¸® ½ÃÀåÀº º´¿ø, ÀÇ·á ¼¾ÅÍ, Àå±â °£È£ ½Ã¼³, ÀçÅà °£È£ ÇöÀå¿¡ ´ëÀÀÇϰí, ¹è¸®¾î Å©¸², Èí¼ö ÆÐµå, °íµµ »óó ÇǺ¹Àç µîÀÇ Á¦Ç°À» Á¦°øÇÕ´Ï´Ù. ¼öºÐ ÇÇÇØ¿Í °ü·ÃµÈ ÇǺΠÁúȯÀÇ À¯º´·ü Áõ°¡¿Í °í·ÉÈ­ Àα¸ Áõ°¡´Â ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:

¼¼°èÀÇ MASD °ü¸® ½ÃÀåÀº MASD¿¡ ´ëÇÑ ÀνÄÀÌ Áõ°¡Çϰí ȯÀÚ°¡ QOL¿¡ ¹ÌÄ¡´Â ¿µÇâ°ú °°Àº ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. °í·ÉÈ­ »çȸ¿¡¼­ÀÇ ½Ç±Ý ¹× °ü·Ã ÇǺΠÁúȯ ¹ß»ý·ü Áõ°¡´Â È¿°úÀûÀÎ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡, ÀÇ·á Á¦Ç°ÀÇ Áøº¸¿Í º¸´Ù È¿À²ÀûÀÎ »óó ÄÉ¾î ¹× À庮 Ä¡·áÀÇ °³¹ßÀº ȯÀÚÀÇ °á°ú¿Í Æí¾ÈÇÔÀÇ Çâ»ó¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. MASDÀÇ ¸ð´ÏÅ͸µ°ú °ü¸®¸¦ À§ÇÑ ÀçÅà Äɾî ȯ°æÀÇ È®´ë¿Í µðÁöÅÐ Çコ ±â¼úÀÇ Ã¤¿ëµµ ½ÃÀå ¼ºÀåÀÇ »õ·Î¿î ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ:

À¯¸ÁÇÑ ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸Çϰí MASD °ü¸® ½ÃÀåÀº MASD Ä¡·á¿¡ ´ëÇÑ »óȯ ¹üÀ§ Á¦ÇѰú °íµµ »óó Äɾî Á¦Ç°ÀÇ ³ôÀº °¡°Ý°ú °°Àº °úÁ¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦ Àå¾Ö¹°, ƯÈ÷ Àå±â ¿ä¾ç ½Ã¼³¿¡¼­ ¿©·¯ ÇÕº´ÁõÀ» °¡Áø ȯÀÚ °ü¸®ÀÇ º¹À⼺µµ ÀÇ·á Á¦°ø¾÷ü¿Í Á¦Á¶¾÷ü¿¡ ¾î·Á¿òÀ» °Þ°í ÀÖ½À´Ï´Ù. ÀϺΠÁö¿ª¿¡¼­´Â Ä¡·á ÇÁ·ÎÅäÄÝÀÌ Ç¥ÁØÈ­µÇÁö ¾Ê¾Ò±â ¶§¹®¿¡ È¿°úÀûÀÎ MASD °ü¸® ¼Ö·ç¼ÇÀÇ º¸±ÞÀÌ ´õ¿í ¾î·Á¿öÁú ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ:

MASD °ü¸® ½ÃÀåÀº ±â¼ú Çõ½Å, Àα¸ µ¿Çâ, ÁøÈ­ÇÏ´Â ÀÇ·á Á¦°ø ¸ðµ¨À» ÅëÇØ Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ¸ÂÃãÇü »óó ÄÉ¾î µå·¹½Ì ¹× À庮 Á¦Ç°°ú °°Àº ȯÀÚ Æ¯È­µÈ Á¦Ç° °³¹ßÀº ½ÃÀå ÁøÃâÀÚ¿¡°Ô Áß¿äÇÑ ±âȸ°¡ µË´Ï´Ù. ¶ÇÇÑ ¿ø°Ý ÀÇ·á Ç÷§Æû°ú ÇǺΠ»óÅÂÀÇ ¿ø°Ý ¸ð´ÏÅ͸µ°ú °°Àº µðÁöÅÐ °Ç°­ ±â¼úÀÇ ÅëÇÕÀº MAD °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ³ôÀ̰í Ä¡·á ¾îµå¹ê½º¸¦ Çâ»ó½Ãŵ´Ï´Ù. Àü·«Àû ÆÄÆ®³Ê½Ê, R&D ÅõÀÚ, ºñ¿ë È¿À²ÀûÀÎ »ç¿ëÀÚ Ä£È­ÀûÀÎ Á¦Ç° ¼Ò°³´Â ÀÌ·¯ÇÑ ±âȸ¸¦ Ȱ¿ëÇÏ°í ½ÃÀå¿¡¼­ ¸®´õ½ÊÀ» À¯ÁöÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´äº¯À» ¾òÀ» ¼ö ÀÖ´Â ÁÖ¿ä Áú¹®

  • MASD °ü¸® ½ÃÀåÀÇ ¼¼°è ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
  • ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼­ MASD °ü¸®¿¡ °¡Àå ¸¹ÀÌ »ç¿ëµÇ´Â Á¦Ç°°ú Ä¡·á¹ýÀº ¹«¾ùÀΰ¡?
  • ±â¼ú Áøº¸´Â MASD °ü¸® ½ÃÀå °æÀï ±¸µµ¸¦ ¾î¶»°Ô Çü¼ºÇϴ°¡?
  • MASD °ü¸® ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº? ¶ÇÇÑ ½ÃÀåÀÇ °ü·Ã¼ºÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» ÃëÇϰí Àִ°¡?
  • ¼¼°èÀÇ MASD °ü¸® ½ÃÀå¿¡¼­ÀÇ »õ·Î¿î µ¿Çâ°ú Àü¸ÁÀº?

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀåÀÇ ¹üÀ§¿Í Á¤ÀÇ
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
    • ÁÖ¿ä µ¿Çâ
  • °Å½Ã°æÁ¦ ¿äÀÎ
    • ¼¼°èÀÇ GDP ¼ºÀå Àü¸Á
    • ¼¼°èÀÇ ÀÇ·áºñ Àü¸Á
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ¿¹Ãø ¿äÀÎ: °ü·Ã¼º°ú ¿µÇâ

Á¦3Àå ºÎ°¡°¡Ä¡ ºÐ¼®

  • ±ÔÁ¦ »óȲ
  • Á¦Ç° ä¿ë ºÐ¼®
  • ÁÖ¿ä °Å·¡¿Í ÇÕº´
  • MASDÀÇ Á¦Ç° Ä«Å×°í¸® ºñ±³
  • PESTLE ºÐ¼®
  • Porter's Five Forces ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ¼öºÐ °ü·Ã ÇǺΠ¼Õ»ó °ü¸® ½ÃÀå Àü¸Á: °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
    • ½ÃÀå ±Ô¸ð¿Í Àü³â´ëºñ ¼ºÀå·ü(±Ý¾× ±âÁØ(10¾ï ´Þ·¯))
    • Àý´ë ¼öÀÍ ±âȸ
  • ½ÃÀå ±Ô¸ðÀÇ ºÐ¼®°ú ¿¹Ãø(±Ý¾× ±âÁØ(10¾ï ´Þ·¯))
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼®(±Ý¾× ±âÁØ(10¾ï ´Þ·¯), 2019-2023³â)
    • ÇöÀç ½ÃÀå ±Ô¸ðÀÇ ºÐ¼®¡¤¿¹Ãø(±Ý¾× ±âÁØ(10¾ï ´Þ·¯), 2025-2032³â)
  • ¼¼°è ¼öºÐ °ü·Ã ÇǺΠ¼Õ»ó °ü¸® ½ÃÀå Àü¸Á : Á¦Ç°º°
    • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : Á¦Ç°º°(±Ý¾× ±âÁØ(10¾ï ´Þ·¯), 2019-2023³â)
    • ÇöÀç ½ÃÀå ±Ô¸ðÀÇ ºÐ¼®°ú ¿¹Ãø : Á¦Ç°º°(±Ý¾× ±âÁØ(10¾ï ´Þ·¯), 2025-2032³â)
      • ¹Ù¼¿¸° ±â¹Ý ¹è¸®¾î
      • »êÈ­¾Æ¿¬°è ¹è¸®¾î
      • ½Ç¸®ÄÜ°è ¹è¸®¾î
      • ½Ã¾Æ³ë¾ÆÅ©¸±·¹ÀÌÆ®-Æú¸®¸Ó Çʸ§ ¹è¸®¾î
      • BCT ¿¡ÀÌÀüÆ®
    • ½ÃÀå ¸Å·Â ºÐ¼® : Á¦Ç°º°
  • ¼¼°èÀÇ ¼öºÐ °ü·Ã ÇǺΠ¼Õ»ó °ü¸® ½ÃÀå Àü¸Á: Çü»óº°
    • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : Çü»óº°(±Ý¾× ±âÁØ(10¾ï ´Þ·¯), 2019-2023³â)
    • ÇöÀç ½ÃÀå ±Ô¸ðÀÇ ºÐ¼®°ú ¿¹Ãø : Çü»óº°(±Ý¾× ±âÁØ(10¾ï ´Þ·¯), 2025-2032³â)
      • °Ö
      • Å©¸²
      • ·Î¼Ç
      • ¿¬°í
      • ±âŸ
    • ½ÃÀå ¸Å·Â ºÐ¼® : Çü»óº°
  • ¼¼°è ¼öºÐ °ü·Ã ÇǺΠ¼Õ»ó °ü¸® ½ÃÀå Àü¸Á : ÀûÀÀÁõº°
    • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : ÀûÀÀÁõº°(±Ý¾× ±âÁØ(10¾ï ´Þ·¯), 2019-2023³â)
    • ÇöÀç ½ÃÀå ±Ô¸ðÀÇ ºÐ¼®°ú ¿¹Ãø : ÀûÀÀÁõº°(±Ý¾× ±âÁØ(10¾ï ´Þ·¯), 2025-2032³â)
      • Æä¸®½ºÅä¸Ó ½À±â °ü·Ã ÇǺο°
      • »óó ÁÖÀ§ ½À±â¿¡ ÀÇÇÑ ÇǺο°
      • ½Ç±Ý °ü·Ã ÇǺο°
      • °£Âû¼º ÇǺο°
      • ħÁ·º´(ÂüÈ£Á·)
    • ½ÃÀå ¸Å·Â ºÐ¼® : ÀûÀÀÁõº°
  • ¼¼°è ¼öºÐ °ü·Ã ÇǺΠ¼Õ»ó °ü¸® ½ÃÀå Àü¸Á : À¯Åë ä³Îº°
    • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : À¯Åëä³Îº°(±Ý¾× ±âÁØ(10¾ï ´Þ·¯), 2019-2023³â)
    • ÇöÀç ½ÃÀå ±Ô¸ðÀÇ ºÐ¼®°ú ¿¹Ãø : À¯Åëä³Îº°(±Ý¾× ±âÁØ(10¾ï ´Þ·¯), 2025-2032³â)
      • ¼Ò¸Å ¾à±¹ ¹× µå·°½ºÅä¾î
      • Áø·á¼Ò ¹× º´¿ø ¾à±¹
      • ¿Â¶óÀÎ ¾à±¹
    • ½ÃÀå ¸Å·Â ºÐ¼® : À¯Åë ä³Îº°

Á¦5Àå ¼¼°èÀÇ ¼öºÐ °ü·Ã ÇǺΠ¼Õ»ó °ü¸® ½ÃÀå Àü¸Á : Áö¿ªº°

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : Áö¿ªº°(±Ý¾× ±âÁØ(10¾ï ´Þ·¯), 2019-2023³â)
  • ÇöÀç ½ÃÀå ±Ô¸ðÀÇ ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°(±Ý¾× ±âÁØ(10¾ï ´Þ·¯), 2025-2032³â)
    • ºÏ¹Ì
    • À¯·´
    • µ¿¾Æ½Ã¾Æ
    • ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾Æ
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀå ¸Å·Â ºÐ¼® :Áö¿ªº°

Á¦6Àå ºÏ¹Ì ¼öºÐ °ü·Ã ÇǺΠ¼Õ»ó °ü¸® ½ÃÀå Àü¸Á: °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

Á¦7Àå À¯·´ÀÇ ¼öºÐ °ü·Ã ÇǺΠ¼Õ»ó °ü¸® ½ÃÀå Àü¸Á: °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

Á¦8Àå µ¿¾Æ½Ã¾ÆÀÇ ¼öºÐ °ü·Ã ÇǺΠ¼Õ»ó °ü¸® ½ÃÀå Àü¸Á: °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

Á¦9Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ ¼öºÐ °ü·Ã ÇǺΠ¼Õ»ó °ü¸® ½ÃÀå Àü¸Á: °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ¼öºÐ °ü·Ã ÇǺΠ¼Õ»ó °ü¸® ½ÃÀå Àü¸Á: °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¼öºÐ °ü·Ã ÇǺΠ¼Õ»ó °ü¸® ½ÃÀå Àü¸Á: °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2025-2032³â)

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • ½ÃÀå ±¸Á¶
    • °æÀï °­µµ ¸ÅÇÎ : ½ÃÀ庰
    • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ(»ó¼¼: °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
    • 3M
    • Medline Industries, Inc.
    • Dynarex Corporation
    • Coloplast Corp.
    • Wellona Pharma
    • Cardinal Health
    • Stryker Sage(Stryker)
    • DermaRite Industries, LLC.
    • AMERX Health Care Corp.
    • Calmoseptine, Inc.
    • PAUL HARTMANN AG
    • Smith Nephew, Inc.
    • Gentell
    • UNIFARCO SpA
    • Others

Á¦13Àå ºÎ·Ï

  • ºÐ¼® ¹æ¹ý
  • ºÐ¼®ÀÇ ÀüÁ¦Á¶°Ç
  • µÎÀÚ¾î ¹× ¾à¾î
JHS 25.02.20

Persistence Market Research has recently released a comprehensive report on the worldwide market for Moisture-associated Skin Damage (MASD) management. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global MASD management market from 2025 to 2032.

Key Insights:

  • MASD Management Market Size (2025E): US$ 4.4 Bn
  • Projected Market Value (2032F):US$ 6.8 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 6.5%

Moisture-associated Skin Damage Management Market - Report Scope:

Moisture-associated Skin Damage refers to skin injury caused by excessive moisture, often due to incontinence or prolonged exposure to sweat. MASD management focuses on the prevention, diagnosis, and treatment of such skin conditions through various medical devices, products, and therapies. The MASD management market caters to hospitals, healthcare centers, long-term care facilities, and homecare settings, offering products such as barrier creams, absorbent pads, and advanced wound dressings. The increasing prevalence of skin conditions associated with moisture damage and the rising aging population are key drivers of market growth.

Market Growth Drivers:

The global MASD management market is propelled by several key factors, including the growing awareness of MASD and its impact on patients' quality of life. The increasing incidence of incontinence and related skin conditions among the aging population further drives the demand for effective management solutions. Moreover, advancements in medical products and the development of more efficient wound care and barrier treatments contribute to enhanced patient outcomes and comfort. The expansion of homecare settings and the adoption of digital health technologies for monitoring and managing MASD also create new opportunities for market growth.

Market Restraints:

Despite promising growth prospects, the MASD management market faces challenges such as limited reimbursement coverage for MASD treatments and the high cost of advanced wound care products. Regulatory hurdles and the complexity of managing patients with multiple comorbidities, especially in long-term care facilities, also pose challenges for healthcare providers and manufacturers. The lack of standardized treatment protocols in some regions may further complicate the widespread adoption of effective MASD management solutions.

Market Opportunities:

The MASD management market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The development of patient-specific products, including customized wound care dressings and barrier products, represents a key opportunity for market players. Furthermore, the integration of telemedicine platforms and digital health technologies, such as remote monitoring of skin conditions, enhances the accessibility of MASD management solutions and improves treatment adherence. Strategic partnerships, investment in R&D, and the introduction of cost-effective and user-friendly products are essential to capitalize on these opportunities and sustain market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the MASD management market globally?
  • Which products and therapies are most commonly used in managing MASD across different healthcare settings?
  • How are technological advancements shaping the competitive landscape of the MASD management market?
  • Who are the key players contributing to the MASD management market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global MASD management market?

Competitive Intelligence and Business Strategy:

Leading players in the global MASD management market, including Coloplast, ConvaTec, and Molnlycke Health Care, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest heavily in R&D to develop advanced wound care solutions, barrier products, and digital health integration for enhanced MASD management. Collaborations with healthcare providers, insurance companies, and regulatory bodies are key strategies to overcome market barriers and expand their customer base. Emphasis on clinical research, evidence-based practices, and patient education fosters market growth and improves patient outcomes.

Key Companies Profiled:

  • Coloplast
  • ConvaTec
  • Molnlycke Health Care
  • Smith & Nephew
  • 3M
  • Hollister Incorporated
  • Medline Industries, Inc.
  • Kimberly-Clark Health Care
  • DermaRite Industries, LLC
  • Acelity Inc.

Moisture-associated Skin Damage Management Market Segmentation

By Product

  • Petrolatum-based Barrier
  • Zinc Oxide-based Barrier
  • Silicone-based Barrier
  • Cyanoacrylates-Polymer Film Barrier
  • BCT Agents

By Form

  • Gel
  • Cream
  • Lotion
  • Ointment

By Indication

  • Peristomal Moisture-associated Dermatitis
  • Periwound Moisture-associated Dermatitis
  • Incontinence-associated Dermatitis
  • Intertriginous Dermatitis
  • Immersion Foot (Trench Foot)

By Distribution Channel

  • Retail Pharmacies and Drug Stores
  • Clinics and Hospital Pharmacies
  • Online Pharmacies

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Moisture-Associated Skin Damage Management Market Snapshot, 2025 - 2032
  • 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Growth Outlook
    • 2.3.2. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Product Adoption Analysis
  • 3.3. Key Deals and Mergers
  • 3.4. Comparison of MASD Products Category
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Global Moisture-Associated Skin Damage Management Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn ) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn ) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn ) Analysis, 2019 - 2023
    • 4.2.2. Current Market Size (US$ Bn ) Analysis and Forecast, 2025 - 2032
  • 4.3. Global Moisture-Associated Skin Damage Management Market Outlook: Product
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn ) Analysis, By Product, 2019 - 2023
    • 4.3.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025 - 2032
      • 4.3.3.1. Petrolatum-based barrier
      • 4.3.3.2. Zinc Oxide-based barrier
      • 4.3.3.3. Silicone-based barrier
      • 4.3.3.4. Cyanoacrylates- Polymer Film Barrier
      • 4.3.3.5. BCT Agents
    • 4.3.4. Market Attractiveness Analysis: Product
  • 4.4. Global Moisture-Associated Skin Damage Management Market Outlook: Form
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn ) Analysis, By Form, 2019 - 2023
    • 4.4.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Form, 2025 - 2032
      • 4.4.3.1. Gel
      • 4.4.3.2. Cream
      • 4.4.3.3. Lotion
      • 4.4.3.4. Ointment
      • 4.4.3.5. Others
    • 4.4.4.Market Attractiveness Analysis: Form
  • 4.5. Global Moisture-Associated Skin Damage Management Market Outlook: Indication
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn ) Analysis, By Indication, 2019 - 2023
    • 4.5.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Indication, 2025 - 2032
      • 4.5.3.1. Peristomal Moisture-associated Dermatitis
      • 4.5.3.2. Periwound Moisture-associated Dermatitis
      • 4.5.3.3. Incontinence-associated Dermatitis
      • 4.5.3.4. Intertriginous Dermatitis
      • 4.5.3.5. Immersion Foot (Trench Foot)
    • 4.5.4. Market Attractiveness Analysis: Indication
  • 4.6. Global Moisture-Associated Skin Damage Management Market Outlook: Distribution Channel
    • 4.6.1. Introduction / Key Findings
    • 4.6.2. Historical Market Size (US$ Bn ) Analysis, By Distribution Channel, 2019 - 2023
    • 4.6.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      • 4.6.3.1. Retail Pharmacies and Drug Stores
      • 4.6.3.2. Clinics and Hospital Pharmacies
      • 4.6.3.3. Online Pharmacies
    • 4.6.4. Market Attractiveness Analysis: Distribution Channel

5. Global Moisture-Associated Skin Damage Management Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn ) Analysis, By Region, 2019 - 2023
  • 5.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Region, 2025 - 2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Moisture-Associated Skin Damage Management Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019 - 2023
    • 6.2.1. By Country
    • 6.2.2. By Product
    • 6.2.3. By Form
    • 6.2.4. By Indication
    • 6.2.5. By Distribution Channel
  • 6.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025 - 2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025 - 2032
    • 6.4.1. Petrolatum based-barrier
    • 6.4.2. Zinc oxide-based barrier
    • 6.4.3. Silicone based-barrier
    • 6.4.4. Cyanoacrylates- Polymer film barrier
    • 6.4.5. BCT Agents
  • 6.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Form, 2025 - 2032
    • 6.5.1. Gel
    • 6.5.2. Cream
    • 6.5.3. Lotion
    • 6.5.4. Ointment
    • 6.5.5. Others
  • 6.6. Current Market Size (US$ Bn ) Analysis and Forecast, By Indication, 2025 - 2032
    • 6.6.1. Peristomal Moisture-associated Dermatitis
    • 6.6.2. Periwound moisture-associated Dermatitis
    • 6.6.3. Incontinence-associated Dermatitis
    • 6.6.4. Intertriginous Dermatitis
    • 6.6.5. Immersion foot (trench foot) (IF)
  • 6.7. Current Market Size (US$ Bn ) Analysis and Forecast, By Distribution Channel, 2025 - 2032
    • 6.7.1. Retail Pharmacies and Drug Stores
    • 6.7.2. Clinics and Hospital Pharmacies
    • 6.7.3. Online Pharmacies
  • 6.8. Market Attractiveness Analysis

7. Europe Moisture-Associated Skin Damage Management Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019 - 2023
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Form
    • 7.2.4. By Indication
    • 7.2.5. By Distribution Channel
  • 7.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025 - 2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025 - 2032
    • 7.4.1. Petrolatum based-barrier
    • 7.4.2. Zinc oxide-based barrier
    • 7.4.3. Silicone based-barrier
    • 7.4.4. Cyanoacrylates- Polymer film barrier
    • 7.4.5. BCT Agents
  • 7.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Form, 2025 - 2032
    • 7.5.1. Gel
    • 7.5.2. Cream
    • 7.5.3. Lotion
    • 7.5.4. Ointment
    • 7.5.5. Others
  • 7.6. Current Market Size (US$ Bn ) Analysis and Forecast, By Indication, 2025 - 2032
    • 7.6.1. Peristomal Moisture-associated Dermatitis
    • 7.6.2. Periwound moisture-associated Dermatitis
    • 7.6.3. Incontinence-associated Dermatitis
    • 7.6.4. Intertriginous Dermatitis
    • 7.6.5. Immersion foot (trench foot) (IF)
  • 7.7. Current Market Size (US$ Bn ) Analysis and Forecast, By Distribution Channel, 2025 - 2032
    • 7.7.1. Retail Pharmacies and Drug Stores
    • 7.7.2. Clinics and Hospital Pharmacies
    • 7.7.3. Online Pharmacies
  • 7.8. Market Attractiveness Analysis

8. East Asia Moisture-Associated Skin Damage Management Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019 - 2023
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Form
    • 8.2.4. By Indication
    • 8.2.5. By Distribution Channel
  • 8.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025 - 2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025 - 2032
    • 8.4.1. Petrolatum based-barrier
    • 8.4.2. Zinc oxide-based barrier
    • 8.4.3. Silicone based-barrier
    • 8.4.4. Cyanoacrylates- Polymer film barrier
    • 8.4.5. BCT Agents
  • 8.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Form, 2025 - 2032
    • 8.5.1. Gel
    • 8.5.2. Cream
    • 8.5.3. Lotion
    • 8.5.4. Ointment
    • 8.5.5. Others
  • 8.6. Current Market Size (US$ Bn ) Analysis and Forecast, By Indication, 2025 - 2032
    • 8.6.1. Peristomal Moisture-associated Dermatitis
    • 8.6.2. Periwound moisture-associated Dermatitis
    • 8.6.3. Incontinence-associated Dermatitis
    • 8.6.4. Intertriginous Dermatitis
    • 8.6.5. Immersion foot (trench foot) (IF)
  • 8.7. Current Market Size (US$ Bn ) Analysis and Forecast, By Distribution Channel, 2025 - 2032
    • 8.7.1. Retail Pharmacies and Drug Stores
    • 8.7.2. Clinics and Hospital Pharmacies
    • 8.7.3. Online Pharmacies
  • 8.8. Market Attractiveness Analysis

9. South Asia & Oceania Moisture-Associated Skin Damage Management Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019 - 2023
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Form
    • 9.2.4. By Indication
    • 9.2.5. By Distribution Channel
  • 9.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025 - 2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025 - 2032
    • 9.4.1. Petrolatum based-barrier
    • 9.4.2. Zinc oxide-based barrier
    • 9.4.3. Silicone based-barrier
    • 9.4.4. Cyanoacrylates- Polymer film barrier
    • 9.4.5. BCT Agents
  • 9.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Form, 2025 - 2032
    • 9.5.1. Gel
    • 9.5.2. Cream
    • 9.5.3. Lotion
    • 9.5.4. Ointment
    • 9.5.5. Others
  • 9.6. Current Market Size (US$ Bn ) Analysis and Forecast, By Indication, 2025 - 2032
    • 9.6.1. Peristomal Moisture-associated Dermatitis
    • 9.6.2. Periwound moisture-associated Dermatitis
    • 9.6.3. Incontinence-associated Dermatitis
    • 9.6.4. Intertriginous Dermatitis
    • 9.6.5. Immersion foot (trench foot) (IF)
  • 9.7. Current Market Size (US$ Bn ) Analysis and Forecast, By Distribution Channel, 2025 - 2032
    • 9.7.1. Retail Pharmacies and Drug Stores
    • 9.7.2. Clinics and Hospital Pharmacies
    • 9.7.3. Online Pharmacies
  • 9.8. Market Attractiveness Analysis

10. Latin America Moisture-Associated Skin Damage Management Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019 - 2023
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Form
    • 10.2.4. By Indication
    • 10.2.5. By Distribution Channel
  • 10.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025 - 2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025 - 2032
    • 10.4.1. Petrolatum based-barrier
    • 10.4.2. Zinc oxide-based barrier
    • 10.4.3. Silicone based-barrier
    • 10.4.4. Cyanoacrylates- Polymer film barrier
    • 10.4.5. BCT Agents
  • 10.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Form, 2025 - 2032
    • 10.5.1. Gel
    • 10.5.2. Cream
    • 10.5.3. Lotion
    • 10.5.4. Ointment
    • 10.5.5. Others
  • 10.6. Current Market Size (US$ Bn ) Analysis and Forecast, By Indication, 2025 - 2032
    • 10.6.1. Peristomal Moisture-associated Dermatitis
    • 10.6.2. Periwound moisture-associated Dermatitis
    • 10.6.3. Incontinence-associated Dermatitis
    • 10.6.4. Intertriginous Dermatitis
    • 10.6.5. Immersion foot (trench foot) (IF)
  • 10.7. Current Market Size (US$ Bn ) Analysis and Forecast, By Distribution Channel, 2025 - 2032
    • 10.7.1. Retail Pharmacies and Drug Stores
    • 10.7.2. Clinics and Hospital Pharmacies
    • 10.7.3. Online Pharmacies
  • 10.8. Market Attractiveness Analysis

11. Middle East & Africa Moisture-Associated Skin Damage Management Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn ) Analysis, By Market, 2019 - 2023
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Form
    • 11.2.4. By Indication
    • 11.2.5. By Distribution Channel
  • 11.3. Current Market Size (US$ Bn ) Analysis and Forecast, By Country, 2025 - 2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn ) Analysis and Forecast, By Product, 2025 - 2032
    • 11.4.1. Petrolatum based-barrier
    • 11.4.2. Zinc oxide-based barrier
    • 11.4.3. Silicone based-barrier
    • 11.4.4. Cyanoacrylates- Polymer film barrier
    • 11.4.5. BCT Agents
  • 11.5. Current Market Size (US$ Bn ) Analysis and Forecast, By Form, 2025 - 2032
    • 11.5.1. Gel
    • 11.5.2. Cream
    • 11.5.3. Lotion
    • 11.5.4. Ointment
    • 11.5.5. Others
  • 11.6. Current Market Size (US$ Bn ) Analysis and Forecast, By Indication, 2025 - 2032
    • 11.6.1. Peristomal Moisture-associated Dermatitis
    • 11.6.2. Periwound moisture-associated Dermatitis
    • 11.6.3. Incontinence-associated Dermatitis
    • 11.6.4. Intertriginous Dermatitis
    • 11.6.5. Immersion foot (trench foot) (IF)
  • 11.7. Current Market Size (US$ Bn ) Analysis and Forecast, By Distribution Channel, 2025 - 2032
    • 11.7.1. Retail Pharmacies and Drug Stores
    • 11.7.2. Clinics and Hospital Pharmacies
    • 11.7.3. Online Pharmacies
  • 11.8. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. 3M
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Medline Industries, Inc.
    • 12.3.3. Dynarex Corporation
    • 12.3.4. Coloplast Corp.
    • 12.3.5. Wellona Pharma
    • 12.3.6. Cardinal Health
    • 12.3.7. Stryker Sage (Stryker)
    • 12.3.8. DermaRite Industries, LLC.
    • 12.3.9. AMERX Health Care Corp.
    • 12.3.10. Calmoseptine, Inc.
    • 12.3.11. PAUL HARTMANN AG
    • 12.3.12. Smith+Nephew, Inc.
    • 12.3.13. Gentell
    • 12.3.14. UNIFARCO S.p.A.
    • 12.3.15. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦